- AbbVie – Acute Myeloid Leukemia (AML)
Sponsor: AbbVie - Agios Pharmaceuticals, Inc. – Acute Myeloid Leukemia
Sponsor: Agios Pharmaceuticals, Inc. - Alnylam Pharmaceuticals – Amyloidosis, Hereditary
Sponsor: Alnylam Pharmaceuticals - Alnylam Pharmaceuticals – TTR-mediated Amyloidosis
Sponsor: Alnylam Pharmaceuticals - Astellas Pharma Global Development, Inc. – Acute Myeloid Leukemia (AML)
Sponsor: Astellas Pharma Global Development, Inc. - Beijing Cancer Hospital – Thyroid Nodules
Sponsor: Beijing Cancer Hospital - British Columbia Cancer Agency – Thyroid Cancer, Medullary
Sponsor: British Columbia Cancer Agency - Emory University – Acute Myeloid Leukemia
Sponsor: Emory University - Novartis Pharmaceuticals – Acute Myeloid Leukemia (AML) With
Sponsor: Novartis Pharmaceuticals - Novartis Pharmaceuticals – FLT3-mutated Acute Myeloid Leukemia
Sponsor: Novartis Pharmaceuticals - University of California, San Francisco – Acute Myeloid Leukemia
Sponsor: University of California, San Francisco
- Home
- /
- Access Program
- /
- Page 4
Access Programs
- University of California, San Francisco – Osteopetrosis
Sponsor: University of California, San Francisco
- AstraZeneca – Ovarian Cancer
Sponsor: AstraZeneca - AstraZeneca – PSR Ovarian Cancer With a BRCA Mutation
Sponsor: AstraZeneca - Tesaro, Inc. – Recurrent Ovarian Cancer
Sponsor: Tesaro, Inc.
- Children’s Hospital of Philadelphia – Childhood Metastatic Pheochromocytoma
Sponsor: Children's Hospital of Philadelphia
- Baxalta – Pancreatic Cancer
Partner: Idis Sponsor: Baxalta - University of Roma La Sapienza – Pancreatic Cancer
Sponsor: University of Roma La Sapienza - University of Roma La Sapienza – Pancreatic Cancer
Sponsor: University of Roma La Sapienza
- Andrei Iagaru – Pancreatic Neuroendocrine Tumors
Partner: Andrei Iagaru Sponsor: Andrei Iagaru - Johannes Czernin – Pancreatic Neuroendocrine Tumors
Sponsor: Johannes Czernin
- British Columbia Cancer Agency – Paraganglioma
Sponsor: British Columbia Cancer Agency - Children’s Hospital Medical Center, Cincinnati – Paraganglioma
Sponsor: Children's Hospital Medical Center, Cincinnati - Children’s Hospital of Philadelphia – Paraganglioma
Sponsor: Children's Hospital of Philadelphia - Jubilant DraxImage Inc. – Paraganglioma
Sponsor: Jubilant DraxImage Inc. - Molecular Insight Pharmaceuticals, Inc. – Paraganglioma
Sponsor: Molecular Insight Pharmaceuticals, Inc. - University of California, San Francisco – Paraganglioma
Sponsor: University of California, San Francisco
- British Columbia Cancer Agency – Pheochromocytoma
Sponsor: British Columbia Cancer Agency - Children’s Hospital Medical Center, Cincinnati – Pheochromocytoma
Sponsor: Children's Hospital Medical Center, Cincinnati - Children’s Hospital of Philadelphia – Pheochromocytoma
Sponsor: Children's Hospital of Philadelphia - Jubilant DraxImage Inc. – Pheochromocytoma
Sponsor: Jubilant DraxImage Inc. - Molecular Insight Pharmaceuticals, Inc. – Pheochromocytoma
Sponsor: Molecular Insight Pharmaceuticals, Inc. - University of California, San Francisco – Pheochromocytoma
Sponsor: University of California, San Francisco
- European Institute for Evidence Based Osteopathic Medicine – Plagiocephaly
Sponsor: European Institute for Evidence Based Osteopathic Medicine
- Andrei Iagaru – Islet Cell (Pancreatic NET)
Sponsor: Andrei Iagaru - University of Roma La Sapienza – Pancreas
Sponsor: University of Roma La Sapienza
- Novartis Pharmaceuticals – Polycythemia vera
Sponsor: Novartis Pharmaceuticals - Washington University School of Medicine – Polycythemia vera
Sponsor: Washington University School of Medicine
- M. Louise Markert – Primary immunodeficiency disorders
Sponsor: M. Louise Markert
- ArQule – Proteus Syndrome
Sponsor: ArQule
- University of Pittsburgh – Acyl-CoA oxidase deficiency
Sponsor: University of Pittsburgh
- Bayer – Pulmonary arterial hypertension
Sponsor: Bayer - Pfizer – Pulmonary Arterial Hypertension
Sponsor: Pfizer - Pfizer – Pulmonary Arterial Hypertension (PAH)
Sponsor: Pfizer
- University of Pittsburgh – Pyruvate carboxylase deficiency
Sponsor: University of Pittsburgh
- Rigel Pharmaceuticals – Immune Thrombocytopenic Purpura
Sponsor: Rigel Pharmaceuticals
- Children’s Hospital of Philadelphia – Short Bowel Syndrome
Sponsor: Children's Hospital of Philadelphia - St. Luke’s Health System, Boise, Idaho – Short bowel syndrome
Sponsor: St. Luke’s Health System, Boise, Idaho
- Suvankar Majumdar – Sickle cell anemia
Sponsor: Suvankar Majumdar
- U.S. Army Medical Research and Materiel Command – Smallpox
Sponsor: U.S. Army Medical Research and Materiel Command
- Johannes Czernin – Somatostatinoma
Sponsor: Johannes Czernin
- Biogen – Infantile-onset Spinal Muscular Atrophy
Sponsor: Biogen - Biogen – Infantile-onset Spinal Muscular Atrophy (SMA)
Sponsor: Biogen - Novartis Pharmaceuticals – Non-small Cell Lung Cancer (NSCLC)
Sponsor: Novartis Pharmaceuticals - Pfizer – Non Small Cell Lung Cancer Harboring Molecular Alterations
Sponsor: Pfizer - Pfizer – Non Small Cell Lung Cancer With ALK or ROS1 Rearrangement
Sponsor: Pfizer
- Agios Pharmaceuticals, Inc. – Relapsed Adult AML
Sponsor: Agios Pharmaceuticals, Inc. - Agios Pharmaceuticals, Inc. – Relapsed Pediatric AML
Sponsor: Agios Pharmaceuticals, Inc. - Amgen – Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Sponsor: Amgen - Kite Pharma, Inc. – Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory High-Grade B-Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory Primary Mediastinal B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Diffuse Large B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Primary Mediastinal B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite, A Gilead Company – Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor: Kite, A Gilead Company - Kite, A Gilead Company – Relapsed/Refractory High-Grade B-Cell Lymphoma
Sponsor: Kite, A Gilead Company - Kite, A Gilead Company – Relapsed/Refractory Primary Mediastinal B Cell Lymphoma
Sponsor: Kite, A Gilead Company
- Agios Pharmaceuticals, Inc. – Relapsed Adult AML
Sponsor: Agios Pharmaceuticals, Inc. - Agios Pharmaceuticals, Inc. – Relapsed Pediatric AML
Sponsor: Agios Pharmaceuticals, Inc. - Amgen – Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia
Sponsor: Amgen - Kite Pharma, Inc. – Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory High-Grade B-Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory Primary Mediastinal B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Diffuse Large B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Primary Mediastinal B Cell Lymphoma
Sponsor: Kite Pharma, Inc. - Kite, A Gilead Company – Relapsed/Refractory Diffuse Large B Cell Lymphoma
Sponsor: Kite, A Gilead Company - Kite, A Gilead Company – Relapsed/Refractory High-Grade B-Cell Lymphoma
Sponsor: Kite, A Gilead Company - Kite, A Gilead Company – Relapsed/Refractory Primary Mediastinal B Cell Lymphoma
Sponsor: Kite, A Gilead Company
- Seoul National University Hospital – Stevens-johnson Syndrome
Sponsor: Seoul National University Hospital
- Chinese Academy of Medical Sciences – Gastric Cancer.
Sponsor: Chinese Academy of Medical Sciences
- DEKK-TEC, Inc. – Document Safety for DM-CHOC-PEN in AYA Subjects With Advanced Cancer
Sponsor: DEKK-TEC, Inc. - DEKK-TEC, Inc. – Document Safety for DM-CHOC-PEN in Pediatric and Adolescent Subjects With Advanced Cancer
Sponsor: DEKK-TEC, Inc. - Eastern Regional Medical Center – Oncology Patients With Gastroparesis
Sponsor: Eastern Regional Medical Center
- Scynexis, Inc. – Mucocutaneous Candidiasis
Sponsor: Scynexis, Inc.
- University of Minnesota – Clinical and Translational Science Institute – X-linked Adrenoleukodystrophy
Sponsor: University of Minnesota - Clinical and Translational Science Institute